Research Article
Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer
Table 3
Minimum binding energy between the key targets and key ingredients.
| Key targets (PDB ID) | Key ingredients | Binding energy (kcal/mol) |
| TP53 (3TG5) | Quercetin | −8.33 | Kaempferol | −8.05 | Isorhamnetin | −8.72 | AKT1 (4EJN) | Quercetin | −7.58 | Kaempferol | −7.39 | Isorhamnetin | −7.12 | VEGFA (4QAF) | Quercetin | −6.07 | Kaempferol | −5.95 | Isorhamnetin | −6.53 | IL6 (5FUC) | Quercetin | −5.81 | Kaempferol | −5.85 | Isorhamnetin | −5.74 | TNF (6X83) | Quercetin | −7.50 | Kaempferol | −7.56 | Isorhamnetin | −7.65 | CASP3 (1NME) | Quercetin | −6.85 | Kaempferol | −7.03 | Isorhamnetin | −6.61 | EGFR (2RGP) | Quercetin | −7.23 | Kaempferol | −7.25 | Isorhamnetin | −6.74 |
|
|